SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Director/PDMR Shareholding

5 Oct 2009 16:54

RNS Number : 2650A
Consort Medical PLC
05 October 2009
 



NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

1.

Name of the issuer

CONSORT MEDICAL PLC

2.

State whether the notification relates to (i) a transaction notified in accordance with DR3.1.4R(1)(a); or

(ii) DR3.1.1(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328)

of the Companies Act 1985; or

(iii) both (i) and (ii)

BOTH

3.

Name of person discharging managerial responsibilities/director

Jon Glenn, Director

Toby Woolrych, Director

Joe Barry, PDMR

Don Dumoulin, PDMR

Lisa King, PDMR

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person.

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest.

THE NOTIFICATION IS IN RESPECT OF HOLDINGS OF THE PERSONS REFERRED TO

IN 3 ABOVE

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares.

N/A

7.

Name of registered shareholder(s) and, if more than one, the number of shares held by each of them.

N/A

8.

State the nature of the transaction.

N/A

9.

Number of shares, debentures or financial instruments relating to shares acquired.

N/A

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage).

N/A

11.

Number of shares, debentures or financial instruments relating to shares disposed.

N/A

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage).

N/A

13.

Price per share or value of transaction.

N/A

14.

Date and place of transaction.

N/A

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage).

N/A

16.

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes.

N/A

17.

Date of grant.

2 October 2009

18.

Period during which or date on which it can be exercised.

1 October 2012 provided the applicable performance criteria have been satisfied.

19.

Total amount paid (if any) for grant of the option.

NIL

20.

Description of shares or debentures involved (class and number).

Grant of Performance Shares under the Bespak plc 2005 LTIP in respect of ordinary 10p shares as

follows:

Name

Status

Performance Shares

Jonathan Glenn

Director

77,647

Toby Woolrych

Director

47,059

Joe Barry

PDMR

26,471

Lisa King

PDMR

28,235

Don Dumoulin

PDMR

41,386

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise.

£4.25

22.

Total number of shares or debentures over which options held following notification.

Name

Status

Performance Shares

Jonathan Glenn

Director

153,230

Toby Woolrych

Director

84,848

Joe Barry

Director

54,747

Lisa King

Director

47,115

Don Dumoulin

Director

81,169

23.

Any additional information.

NONE

24.

Name of contact and telephone number for queries.

Robert Allnutt

Company Secretary

01442 867924

Name and signature of duly authorised officer or issuer responsible for making notification.

Robert Allnutt

Date of Notification

5 October 2009

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEELFBKBBZFBQ
Date   Source Headline
15th Jun 20123:12 pmRNSDirector/PDMR Shareholding
14th Jun 20127:00 amRNSDirectorate
14th Jun 20127:00 amRNSPreliminary Results
6th Jun 20121:57 pmRNSBlocklisting Interim Review
1st May 201210:21 amRNSTotal Voting Rights
30th Apr 20127:00 amRNSFDA Approval Proprietary Integrated Dose Counter
20th Apr 201210:54 amRNSHolding(s) in Company
16th Apr 201211:37 amRNSBlocklisting Interim Review
28th Mar 20124:36 pmRNSHolding(s) in Company
22nd Mar 20129:58 amRNSAnnual Information Update
20th Mar 20124:25 pmRNSReplacement Interim Management Statement
20th Mar 20121:07 pmRNSInterim Management Statement
1st Mar 20129:00 amRNSTotal Voting Rights
17th Feb 201210:09 amRNSHolding(s) in Company
23rd Jan 20129:45 amRNSBlocklisting Interim Review
13th Dec 20112:25 pmRNSDirector/PDMR Shareholding
2nd Dec 20111:34 pmRNSBlocklisting Interim Review
1st Dec 20117:00 amRNSInterim results for the six months ended 31/10/11
19th Oct 20114:03 pmRNSHolding(s) in Company
17th Oct 20113:13 pmRNSHolding(s) in Company
14th Oct 20119:39 amRNSBlocklisting Interim Review
7th Oct 201112:13 pmRNSHolding(s) in Company
5th Oct 20114:47 pmRNSHolding(s) in Company
4th Oct 20117:00 amRNSSecond Nasal Drug Delivery Contract
27th Sep 20114:33 pmRNSHolding(s) in Company
26th Sep 20113:01 pmRNSHolding(s) in Company
2nd Sep 201110:21 amRNSTotal Voting Rights
1st Sep 20112:50 pmRNSResult of AGM
1st Sep 20112:47 pmRNSDirectorate Change
1st Sep 201112:40 pmRNSInterim Management Statement
1st Sep 20117:00 amRNSNasal Drug Delivery Contract
24th Aug 20114:35 pmRNSHolding(s) in Company
2nd Aug 20111:51 pmRNSDirector/PDMR Shareholding
2nd Aug 20111:47 pmRNSDirector/PDMR Shareholding
28th Jul 20119:14 amRNSAnnual Financial Report
20th Jul 20117:00 amRNSFurther re Investment in Atlas Genetics
30th Jun 20111:58 pmRNSTotal Voting Rights
24th Jun 20119:06 amRNSHolding(s) in Company
21st Jun 201112:33 pmRNSBlocklisting Interim Review
16th Jun 20117:00 amRNSPreliminary results for the year ended 30/04/11
2nd Jun 20117:00 amRNSBlocklisting Interim Review
10th May 20119:27 amRNSHolding(s) in Company
14th Apr 201110:20 amRNSBlocklisting Interim Review
4th Apr 201110:29 amRNSHolding(s) in Company
1st Apr 20111:51 pmRNSHolding(s) in Company
23rd Mar 20112:04 pmRNSAnnual Information Update
14th Mar 20117:00 amRNSInterim Management Statement
15th Feb 20114:14 pmRNSHolding(s) in Company
9th Feb 201111:15 amRNSDirectorate Change
7th Feb 20117:00 amRNSPartners with Atlas Genetics

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.